Metamfetamine is a sympathomimetic agent used in the treatment of attention deficit hyperactivity disorder (ADHD) and exogenous obesity. Metamfetamine (methamphetamine) is a psychostimulant and sympathomimetic drug, and a member of the amphetamine group of sympathomimetic amines.
- Mechanism
- Curator reviewed
Methamphetamine enters the brain and triggers a cascading release of norepinephrine, dopamine and serotonin. To a lesser extent methamphetamine acts as a dopaminergic and adrenergic reuptake inhibitor and in high concentrations as a monamine oxidase inhibitor (MAOI). The mechanism of action involved in producing the beneficial behavioral changes seen in hyperkinetic children receiving methamphetamine is unknown.
- Primary indication
- For the treatment of Attention Deficit Disorder with Hyperactivity (ADHD) and exogenous obesity.Curator reviewed · 3 structured indications
- Formula / weight
- C10H15N · 149.2328 g/mol (avg)
- First approval
- United States, 1943
- Also known as
- d-deoxyephedrine · d-desoxyephedrine · d-N-methylamphetamine · d-phenylisopropylmethylamine · Dextromethamphetamine
- Code names
- J6.362B · NSC-25115
- Brand names
Resolves to
MYWUZJCMWCOHBA-VIFPVBQESA-NSMILESCN[C@@H](C)CC1=CC=CC=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Metamfetamine, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account